Primary Cells Market Research Report - Forecast till 2030

Primary Cells Market Research Report Information By Source (Hematopoietic Cells, Skin Cells, Gastrointestinal Cells, Liver Cells, Lung Cells, and Skeletal and Muscle Cells) by Type (Human Primary Cells and Animal Primary Cells), By End User (Pharmaceutical and Biotechnology Companies and Research Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2030

ID: MRFR/LS/4835-CR | 78 Pages | Author: Kinjoll Dey | January 2020         

1 EXECUTIVE SUMMARY

1.1 OVERVIEW 13

1.1.1 MARKET SYPNOSIS 14

2 MARKET INTRODUCTION

2.1 SCOPE OF THE STUDY 15

2.2 RESEARCH OBJECTIVE 15

2.3 LIST OF ASSUMPTIONS 16

3 RESEARCH METHODOLOGY

.1.1 OVERVIEW 17

3.2 DATA MINING 17

3.3 SECONDARY RESEARCH 18

3.4 PRIMARY RESEARCH 19

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 19

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 20

3.5 FORECASTING TECHNIQUES 20

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21

3.6.1 BOTTOM-UP APPROACH 22

3.6.2 TOP-DOWN APPROACH 22

3.7 DATA TRIANGULATION 23

3.8 VALIDATION 23

4 MARKET DYNAMICS

4.1 OVERVIEW 24

4.2 DRIVERS 25

4.2.1 GROWING CANCER RESEARCH 25

4.2.2 WIDE RANGE OF APPLICATION OF PRIMARY CELLS FOR DISEASE TREATMENT 25

4.2.3 ADVANTAGES OF PRIMARY HUMAN CELLS OVER CELL LINES 25

4.2.4 GROWING RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES 25

4.3 RESTRAINTS 27

4.3.1 RISK OF CONTAMINATION 27

4.3.2 HIGH COST OF ADVANCED PRIMARY CELLS 27

4.4 OPPORTUNITIES 28

4.4.1 INCREASING DEMAND FOR PRIMARY CELL IN RESEARCH, INNOVATION, AND LAUNCH OF NEW DRUGS 28

5 MARKET FACTOR ANALYSIS

5.1 PORTER’S FIVE FORCES MODEL 29

5.1.1 THREAT OF NEW ENTRANTS 29

5.1.2 BARGAINING POWER OF SUPPLIERS 30

5.1.3 THREAT OF SUBSTITUTES 30

5.1.4 BARGAINING POWER OF BUYERS 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 VALUE CHAIN ANALYSIS 31

5.2.1 R&D AND MANUFACTURING 32

5.2.2 DISTRIBUTION 32

5.2.3 MARKETING & SALES 32

6 PRIMARY CELLS MARKET, BY SOURCE

6.1 OVERVIEW 33

6.2 HEMATOPOIETIC CELLS 35

6.3 SKIN CELLS 36

6.4 GASTROINTESTINAL CELLS 36

6.5 LIVER CELLS 36

6.6 LUNG CELLS 37

6.7 SKELETAL AND MUSCLE CELLS 37

7 PRIMARY CELLS MARKET, BY TYPE

7.1 OVERVIEW 38

7.2 HUMAN PRIMARY CELLS 39

7.3 ANIMAL PRIMARY CELLS 40

8 PRIMARY CELLS MARKET, BY END USER

8.1 OVERVIEW 41

8.2 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 43

8.3 RESEARCH INSTITUTES 43

9 GLOBAL PRIMARY CELLS MARKET, BY REGION

9.1 OVERVIEW 44

9.2 AMERICAS 46

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.2.1 NORTH AMERICA 48

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.2.1.1 US 49

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.2.1.2 CANADA 50

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.2.2 LATIN AMERICA 51

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3 EUROPE 53

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1 WESTERN EUROPE 55

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.1 GERMANY 57

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.2 UK 58

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.3 FRANCE 59

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.4 ITALY 60

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.5 SPAIN 61

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.1.6 REST OF WESTERN EUROPE 62

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.3.2 EASTERN EUROPE 63

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4 ASIA-PACIFIC 64

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.1 JAPAN 66

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.2 CHINA 67

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.3 INDIA 68

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.4 AUSTRALIA 69

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.5 SOUTH KOREA 70

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.4.6 REST OF ASIA PACIFIC 71

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.5 MIDDLE EAST & AFRICA 72

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.5.1 MIDDLE EAST 74

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

9.5.2 AFRICA 75

PRIMARY CELLS MARKET, BY SOURCE

PRIMARY CELLS MARKET, BY TYPE

PRIMARY CELLS MARKET, BY END USER

10 COMPETITIVE LANDSCAPE

10.1 OVERVIEW 76

10.2 COMPETITIVE ANALYSIS 76

11 COMPANY PROFILES

11.1 ALLCELLS 77

11.1.1 COMPANY OVERVIEW 77

11.1.2 FINANCIAL OVERVIEW 77

11.1.3 PRODUCTS/SERVICES OFFERED 77

11.1.4 KEY DEVELOPMENTS 77

11.1.5 SWOT ANALYSIS 78

11.1.6 KEY STRATEGIES 78

11.2 AMERICAN TYPE CULTURE COLLECTION (ATCC) 79

11.2.1 COMPANY OVERVIEW 79

11.2.2 FINANCIAL OVERVIEW 79

11.2.3 PRODUCTS/SERVICES OFFERED 79

11.2.4 KEY DEVELOPMENTS 79

11.2.5 SWOT ANALYSIS 80

11.2.6 KEY STRATEGIES 80

11.3 AXOL BIOSCIENCE LTD 81

11.3.1 COMPANY OVERVIEW 81

11.3.2 FINANCIAL OVERVIEW 81

11.3.3 PRODUCTS/SERVICES OFFERED 81

11.3.4 KEY DEVELOPMENTS 81

11.3.5 SWOT ANALYSIS 82

11.3.6 KEY STRATEGIES 82

11.4 CELL BIOLOGICS, INC. 83

11.4.1 COMPANY OVERVIEW 83

11.4.2 FINANCIAL OVERVIEW 83

11.4.3 PRODUCTS/SERVICES OFFERED 83

11.4.4 KEY DEVELOPMENTS 83

11.4.5 SWOT ANALYSIS 84

11.4.6 KEY STRATEGIES 84

11.5 LONZA 85

11.5.1 COMPANY OVERVIEW 85

11.5.2 FINANCIAL OVERVIEW 85

11.5.3 PRODUCTS/SERVICES OFFERED 86

11.5.4 KEY DEVELOPMENTS 86

11.5.5 SWOT ANALYSIS 87

11.5.6 KEY STRATEGIES 87

11.6 MERCK KGAA 88

11.6.1 COMPANY OVERVIEW 88

11.6.2 FINANCIAL OVERVIEW 88

11.6.3 PRODUCTS/SERVICES OFFERED 89

11.6.4 KEY DEVELOPMENTS 89

11.6.5 SWOT ANALYSIS 90

11.6.6 KEY STRATEGIES 90

11.7 PROMOCELL 91

11.7.1 COMPANY OVERVIEW 91

11.7.2 FINANCIAL OVERVIEW 91

11.7.3 PRODUCTS/SERVICES OFFERED 91

11.7.4 KEY DEVELOPMENTS 91

11.7.5 SWOT ANALYSIS 92

11.7.6 KEY STRATEGIES 92

11.8 STEMCELL TECHNOLOGIES INC. 93

11.8.1 COMPANY OVERVIEW 93

11.8.2 FINANCIAL OVERVIEW 93

11.8.3 PRODUCTS/SERVICES OFFERED 93

11.8.4 KEY DEVELOPMENTS 93

11.8.5 SWOT ANALYSIS 94

11.8.6 KEY STRATEGIES 94

11.9 ZENBIO, INC. 95

11.9.1 COMPANY OVERVIEW 95

11.9.2 FINANCIAL OVERVIEW 95

11.9.3 PRODUCTS/SERVICES OFFERED 95

11.9.4 KEY DEVELOPMENTS 95

11.9.5 SWOT ANALYSIS 96

11.9.6 KEY STRATEGIES 96

11.10 THERMO FISHER SCIENTIFIC INC. 97

11.10.1 COMPANY OVERVIEW 97

11.10.2 FINANCIAL OVERVIEW 97

11.10.3 PRODUCTS/SERVICES OFFERED 98

11.10.4 KEY DEVELOPMENTS 98

11.10.5 SWOT ANALYSIS 99

11.10.6 KEY STRATEGIES 99

12 APPENDIX

12.1 REFERENCES 100

12.2 RELATED REPORTS 101

13 LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS 16

TABLE 2 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 35

TABLE 3 GLOBAL PRIMARY CELLS MARKET FOR HEMATOPOIETIC CELLS, BY REGION, 2023-2030 (USD MILLION) 35

TABLE 4 GLOBAL PRIMARY CELLS MARKET FOR SKIN CELLS, BY REGION, 2023-2030 (USD MILLION) 36

TABLE 5 GLOBAL PRIMARY CELLS MARKET FOR GASTROINTESTINAL CELLS, BY REGION, 2023-2030 (USD MILLION) 36

TABLE 6 GLOBAL PRIMARY CELLS MARKET FOR LIVER CELLS, BY REGION, 2023-2030 (USD MILLION) 36

TABLE 7 GLOBAL PRIMARY CELLS MARKET FOR LUNG CELLS, BY REGION, 2023-2030 (USD MILLION) 37

TABLE 8 GLOBAL PRIMARY CELLS MARKET FOR SKELETAL AND MUSCLE CELLS, BY REGION, 2023-2030 (USD MILLION) 37

TABLE 9 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 39

TABLE 10 GLOBAL PRIMARY CELLS MARKET FOR HUMAN PRIMARY CELLS, BY REGION, 2023-2030 (USD MILLION) 39

TABLE 11 GLOBAL PRIMARY CELLS MARKET FOR ANIMAL PRIMARY CELLS, BY REGION, 2023-2030 (USD MILLION) 40

TABLE 12 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 42

TABLE 13 GLOBAL PRIMARY CELLS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION,

2023-2030 (USD MILLION) 43

TABLE 14 GLOBAL PRIMARY CELLS MARKET FOR RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION) 43

TABLE 15 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 45

TABLE 16 AMERICAS: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 46

TABLE 17 AMERICAS: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 47

TABLE 18 AMERICAS: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 47

TABLE 19 AMERICAS: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 47

TABLE 20 NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 48

TABLE 21 NORTH AMERICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 48

TABLE 22 NORTH AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 49

TABLE 23 NORTH AMERICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 49

TABLE 24 US: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 49

TABLE 25 US: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 50

TABLE 26 US: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 50

TABLE 27 CANADA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 50

TABLE 28 CANADA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 51

TABLE 29 CANADA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 51

TABLE 30 LATIN AMERICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 51

TABLE 31 LATIN AMERICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 52

TABLE 32 LATIN AMERICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 52

TABLE 33 EUROPE: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 53

TABLE 34 EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 54

TABLE 35 EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 54

TABLE 36 EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 54

TABLE 37 WESTERN EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 55

TABLE 38 WESTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 56

TABLE 39 WESTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 56

TABLE 40 WESTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 56

TABLE 41 GERMANY: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 57

TABLE 42 GERMANY: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 57

TABLE 43 GERMANY: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 57

TABLE 44 UK: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 58

TABLE 45 UK: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 58

TABLE 46 UK: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 58

TABLE 47 FRANCE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 59

TABLE 48 FRANCE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 59

TABLE 49 FRANCE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 59

TABLE 50 ITALY: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 60

TABLE 51 ITALY: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 60

TABLE 52 ITALY: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 60

TABLE 53 SPAIN: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 61

TABLE 54 SPAIN: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 61

TABLE 55 SPAIN: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 61

TABLE 56 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 62

TABLE 57 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 62

TABLE 58 REST OF WESTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 62

TABLE 59 EASTERN EUROPE: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 63

TABLE 60 EASTERN EUROPE: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 63

TABLE 61 EASTERN EUROPE: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 63

TABLE 62 ASIA-PACIFIC: PRIMARY MARKET, BY COUNTRY, 2023-2030 (USD MILLION) 64

TABLE 63 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 65

TABLE 64 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 65

TABLE 65 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 65

TABLE 66 JAPAN: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 66

TABLE 67 JAPAN: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 66

TABLE 68 JAPAN: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 66

TABLE 69 CHINA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 67

TABLE 70 CHINA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 67

TABLE 71 CHINA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 67

TABLE 72 INDIA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 68

TABLE 73 INDIA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 68

TABLE 74 INDIA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 68

TABLE 75 AUSTRALIA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 69

TABLE 76 AUSTRALIA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 69

TABLE 77 AUSTRALIA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 69

TABLE 78 SOUTH KOREA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 70

TABLE 79 SOUTH KOREA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 70

TABLE 80 SOUTH KOREA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 70

TABLE 81 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 71

TABLE 82 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 71

TABLE 83 REST OF ASIA-PACIFIC: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 71

TABLE 84 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY REGION, 2023-2030 (USD MILLION) 72

TABLE 85 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 73

TABLE 86 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 73

TABLE 87 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 73

TABLE 88 MIDDLE EAST: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 74

TABLE 89 MIDDLE EAST: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 74

TABLE 90 MIDDLE EAST: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 74

TABLE 91 AFRICA: PRIMARY CELLS MARKET, BY SOURCE, 2023-2030 (USD MILLION) 75

TABLE 92 AFRICA: PRIMARY CELLS MARKET, BY TYPE, 2023-2030 (USD MILLION) 75

TABLE 93 AFRICA: PRIMARY CELLS MARKET, BY END USER, 2023-2030 (USD MILLION) 75

TABLE 94 ALLCELLS: PRODUCTS/SERVICES OFFERED 77

TABLE 95 AMERICAN TYPE CULTURE COLLECTION (ATCC): PRODUCTS/SERVICES OFFERED 79

TABLE 96 AXOL BIOSCIENCE LTD: PRODUCTS/SERVICES OFFERED 81

TABLE 97 CELL BIOLOGICS, INC.: PRODUCTS/SERVICES OFFERED 83

TABLE 98 LONZA: PRODUCTS/SERVICES OFFERED 86

TABLE 99 LONZA: KEY DEVELOPMENTS 86

TABLE 100 MERCK KGAA: PRODUCTS/SERVICES OFFERED 89

TABLE 101 PROMOCELL: PRODUCTS/SERVICES OFFERED 91

TABLE 102 STEMCELL TECHNOLOGIES INC.: PRODUCTS/SERVICES OFFERED 93

TABLE 103 ZENBIO, INC.: PRODUCTS/SERVICES OFFERED 95

TABLE 104 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES OFFERED 98

14 LIST OF FIGURES

FIGURE 1 GLOBAL PRIMARY CELLS MARKET STRUCTURE 16

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 22

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRIMARY CELL MARKET 24

FIGURE 4 DRIVERS IMPACT ANALYSIS 26

FIGURE 5 RESTRAINTS IMPACT ANALYSIS 27

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRIMARY CELL MARKET 29

FIGURE 7 VALUE CHAIN ANALYSIS OF THE GLOBAL PRIMARY CELL MARKET 31

FIGURE 8 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023 (%) 34

FIGURE 9 GLOBAL PRIMARY CELLS MARKET, BY SOURCE, 2023 & 2030 (USD MILLION) 34

FIGURE 10 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023 (%) 38

FIGURE 11 GLOBAL PRIMARY CELLS MARKET, BY TYPE, 2023 & 2030 (USD MILLION) 39

FIGURE 12 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023 (%) 42

FIGURE 13 GLOBAL PRIMARY CELLS MARKET, BY END USER, 2023 & 2030 (USD MILLION) 42

FIGURE 14 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023(%) 44

FIGURE 15 GLOBAL PRIMARY CELLS MARKET, BY REGION, 2023 & 2030 (USD MILLION) 45

FIGURE 16 AMERICAS: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 46

FIGURE 17 NORTH AMERICA: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 48

FIGURE 18 EUROPE: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 53

FIGURE 19 WESTERN EUROPE: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 55

FIGURE 20 ASIA-PACIFIC: PRIMARY CELLS MARKET, BY COUNTRY, 2023 (%) 64

FIGURE 21 MIDDLE EAST & AFRICA: PRIMARY CELLS MARKET, BY REGION, 2023 (%) 72

FIGURE 22 GLOBAL PRIMARY CELLS MAJOR PLAYERS MARKET SHARE ANALYSIS, 2023 (%) 76

FIGURE 23 ALLCELLS: SWOT ANALYSIS 78

FIGURE 24 AMERICAN TYPE CULTURE COLLECTION (ATCC): SWOT ANALYSIS 80

FIGURE 25 AXOL BIOSCIENCE LTD: SWOT ANALYSIS 82

FIGURE 26 CELL BIOLOGICS, INC.: SWOT ANALYSIS 84

FIGURE 27 LONZA: SWOT ANALYSIS 87

FIGURE 28 MERCK KGAA: FINANCIAL OVERVIEW SNAPSHOT 88

FIGURE 29 MERCK KGAA: SWOT ANALYSIS 90

FIGURE 30 PROMOCELL: SWOT ANALYSIS 92

FIGURE 31 STEMCELL TECHNOLOGIES INC.: SWOT ANALYSIS 94

FIGURE 32 ZENBIO, INC.: SWOT ANALYSIS 96

FIGURE 33 THERMO FISHER SCIENTIFIC INC.: FINANCIAL OVERVIEW 97

FIGURE 34 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 99




Primary Cells Market Segmentation


Primary Cells Source Outlook (USD Billion, 2018-2030)




  • Hematopoietic Cells




  • Skin Cells




  • Gastrointestinal Cells




  • Liver Cells




  • Lung Cells




  • Skeletal and Muscle Cells




Primary Cells Type Outlook (USD Billion, 2018-2030)




  • Human Primary Cells




  • Animal Primary Cells




Primary Cells End User Outlook (USD Billion, 2018-2030)




  • Pharmaceutical and Biotechnology Companies




  • Research Institutes




Primary Cells Regional Outlook (USD Billion, 2018-2030)




  • North America Outlook (USD Billion, 2018-2030)




    • North America Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • North America Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • North America Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • US Outlook (USD Billion, 2018-2030)




    • US Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • US Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • US Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • CANADA Outlook (USD Billion, 2018-2030)




    • CANADA Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • CANADA Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • CANADA Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes








  • Europe Outlook (USD Billion, 2018-2030)




    • Europe Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Europe Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Europe Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Germany Outlook (USD Billion, 2018-2030)




    • Germany Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Germany Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Germany Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • France Outlook (USD Billion, 2018-2030)




    • France Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • France Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • France Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • UK Outlook (USD Billion, 2018-2030)




    • UK Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • UK Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • UK Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • ITALY Outlook (USD Billion, 2018-2030)




    • ITALY Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • ITALY Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • ITALY Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes














    • SPAIN Outlook (USD Billion, 2018-2030)




    • Spain Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Spain Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Spain Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Rest Of Europe Outlook (USD Billion, 2018-2030)




    • Rest Of Europe Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • REST OF EUROPE Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • REST OF EUROPE Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes







  • Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Asia-Pacific Primary Cells by Source




      • Human Primary Cells




      • Animal Primary Cells






    • Asia-Pacific Primary Cells by Type




      • Flat-Rolled




      • Castings




      • Extrusions




      • Forgings




      • Pigments & Powder




      • Rod & Bar






    • Asia-Pacific Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes














    • China Outlook (USD Billion, 2018-2030)




    • China Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • China Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • China Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Japan Outlook (USD Billion, 2018-2030)




    • Japan Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Japan Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Japan Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • India Outlook (USD Billion, 2018-2030)




    • India Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells













    • India Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • India Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Australia Outlook (USD Billion, 2018-2030)




    • Australia Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Australia Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Australia Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Rest of Asia-Pacific Outlook (USD Billion, 2018-2030)




    • Rest of Asia-Pacific Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Rest of Asia-Pacific Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Rest of Asia-Pacific Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes







  • Rest of the World Outlook (USD Billion, 2018-2030)




    • Rest of the World Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Rest of the World Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Rest of the World Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes














    • Middle East Outlook (USD Billion, 2018-2030)




    • Middle East Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Middle East Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Middle East Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Africa Outlook (USD Billion, 2018-2030)




    • Africa Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Africa Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Africa Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes






    • Latin America Outlook (USD Billion, 2018-2030)




    • Latin America Primary Cells by Source




      • Hematopoietic Cells




      • Skin Cells




      • Gastrointestinal Cells




      • Liver Cells




      • Lung Cells




      • Skeletal and Muscle Cells






    • Latin America Primary Cells by Type




      • Human Primary Cells




      • Animal Primary Cells






    • Latin America Primary Cells by End User




      • Pharmaceutical and Biotechnology Companies




      • Research Institutes
























Leading companies partner with us for data-driven Insights.
Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon Report List icon

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response
Invalid